Wadih Arap

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: The University of Texas System, Sloan-Kettering Institute for Cancer Research, William Marsh Rice University. Active years: 2001-2024.

USPTO Granted Patents = 23 (Patent Applications = 11)

% Patents Active = 52.2

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 192(Granted Patents)

Location History:

Solana Beach, CA (US) (2003)
Houston, TX (US) (2001 - 2020)
Los Ranchos de Albuquerque, NM (US) (2021)

Company Filing History:

20 out of 5,630

The University of Texas System

patents

4 out of 518

Sloan-Kettering Institute for Cancer Research

patents

3 out of 659

William Marsh Rice University

patents

4. 2 out of 94

The Burnham Institute

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121525 - Methods for treating GI syndrome and graft versus host disease (2024-10-22),

2. 11207329 - Methods for treating GI syndrome and graft versus host disease (2021-12-28),

3. 10844365 - Systems and methods for magnetic guidance and patterning of materials (2020-11-24),

4. 9909116 - Systems and methods for magnetic guidance and patterning of materials (2018-03-06),

5. 9827327 - Methods and compositions related to adenoassociated virus-phage particles (2017-11-28),

6. 9592238 - Anti-ceramide monoclonal antibody 2A2 (2017-03-14),

7. 8846859 - Compositions and methods of use of targeting peptides against placenta and adipose tissues (2014-09-30),

8. 8815231 - Systems and methods for magnetic guidance and patterning of materials (2014-08-26),

9. 8710017 - Human and mouse targeting peptides identified by phage display (2014-04-29),

10. 8562993 - Methods for treating GI syndrome and graft versus host disease (2013-10-22),

11. 8507445 - Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer (2013-08-13),

12. 8470528 - Methods and compositions related to adenoassociated virus-phage particles (2013-06-25),

13. 8450278 - MUC18 targeting peptides (2013-05-28),

14. 8252764 - Compositions and methods of use of targeting peptides against placenta and adipose tissues (2012-08-28),

15. 8067377 - Peptide compositions for targeting adipose tissue (2011-11-29),

Title: The Innovative Journey of Wadih Arap

Introduction: Wadih Arap, a pioneering inventor based in Houston, Texas, has made significant contributions to the field of innovation through his groundbreaking work in various sectors.

Latest Patents: Wadih Arap holds several patents in the fields of biotechnology, pharmaceuticals, and medical devices, showcasing his commitment to advancing technology for the betterment of society.

Career Highlights: With a distinguished career spanning over two decades, Wadih Arap has been at the forefront of cutting-edge research and development, leading to the creation of revolutionary products and solutions.

Collaborations: Throughout his career, Wadih Arap has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Wadih Arap's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have established him as a visionary inventor whose work continues to inspire and shape the future of technology.